{
    "xml": "<topic id=\"PHP4371\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/methylprednisolone\" basename=\"methylprednisolone\" title=\"METHYLPREDNISOLONE\">\n<title>METHYLPREDNISOLONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_492\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/methylprednisolone\">Methylprednisolone</xref>\n</p>\n<data name=\"vtmid\">27242001</data>\r\n<data name=\"vtmid\">109069007</data>\r\n<data name=\"vtmid\">13331211000001104</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP51872\" outputclass=\"indicationsAndDose\" rev=\"1.15\" parent=\"/drugs/methylprednisolone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders</p>\n<p outputclass=\"therapeuticIndication\">Cerebral oedema associated with malignancy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Usual dose 2&#8211;40&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8211;500&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of graft rejection reactions</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Up to 1&#8239;g daily for up to 3 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51999\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/methylprednisolone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"caution\">rapid intravenous administration of large doses associated with cardiovascular collapse</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52065\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/methylprednisolone\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (as sodium succinate) (<i>Solu-Medrone</i>\n<tm tmtype=\"reg\"/>), give continuously <i>or</i> intermittently <i>or via</i> drip tubing in Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstitute initially with water for injections; doses up to 250&#8239;mg should be given over at least 5 minutes, high doses over at least 30 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51844\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/methylprednisolone\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patient counselling is advised for methylprednisolone tablets and injections (steroid card).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4371-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/methylprednisolone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75654\" title=\"Tablet\" namespace=\"/drugs/methylprednisolone/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75647\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/methylprednisolone/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75640\" title=\"Suspension for injection\" namespace=\"/drugs/methylprednisolone/suspension-for-injection\">Suspension for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88006\" namespace=\"/drugs/lidocaine-with-methylprednisolone\" title=\"LIDOCAINE WITH METHYLPREDNISOLONE\" count=\"1\" rel=\"backlink\">LIDOCAINE WITH METHYLPREDNISOLONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78316\" namespace=\"/treatment-summaries/inflammatory-bowel-disease\" title=\"Inflammatory bowel disease\" count=\"1\" rel=\"backlink\">Inflammatory bowel disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78455\" namespace=\"/treatment-summaries/corticosteroids-inflammatory-disorders\" title=\"Corticosteroids, inflammatory disorders\" count=\"1\" rel=\"backlink\">Corticosteroids, inflammatory disorders</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_492\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/methylprednisolone\" title=\"Methylprednisolone\" count=\"1\" rel=\"link\">Methylprednisolone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75654\" namespace=\"/drugs/methylprednisolone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75647\" namespace=\"/drugs/methylprednisolone/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75640\" namespace=\"/drugs/methylprednisolone/suspension-for-injection\" title=\"Suspension for injection\" count=\"1\" rel=\"link\">Suspension for injection</xref>\n</links>\n</topic>",
    "id": "PHP4371",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/methylprednisolone",
    "basename": "methylprednisolone",
    "title": "METHYLPREDNISOLONE",
    "interactants": [
        {
            "id": "bnf_int_492",
            "label": "Methylprednisolone"
        }
    ],
    "vtmid": "13331211000001104",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders",
                        "html": "Suppression of inflammatory and allergic disorders"
                    },
                    {
                        "textContent": "Cerebral oedema associated with malignancy",
                        "html": "Cerebral oedema associated with malignancy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Usual dose 2&#8211;40 mg daily.",
                        "html": "<p>Usual dose 2&#8211;40&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "Initially 10&#8211;500 mg.",
                        "html": "<p>Initially 10&#8211;500&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of graft rejection reactions",
                        "html": "Treatment of graft rejection reactions"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Up to 1 g daily for up to 3 days.",
                        "html": "<p>Up to 1&#8239;g daily for up to 3 days.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "rapid intravenous administration of large doses associated with cardiovascular collapse",
                "html": "rapid intravenous administration of large doses associated with cardiovascular collapse",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (as sodium succinate) (Solu-Medrone ), give continuously or intermittently or via drip tubing in Glucose 5% or Sodium chloride 0.9%. Reconstitute initially with water for injections; doses up to 250 mg should be given over at least 5 minutes, high doses over at least 30 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (as sodium succinate) (<i>Solu-Medrone</i>\n<tm tmtype=\"reg\"/>), give continuously <i>or</i> intermittently <i>or via</i> drip tubing in Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstitute initially with water for injections; doses up to 250&#8239;mg should be given over at least 5 minutes, high doses over at least 30 minutes.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patient counselling is advised for methylprednisolone tablets and injections (steroid card).",
                "html": "<p>Patient counselling is advised for methylprednisolone tablets and injections (steroid card).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75654",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75647",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75640",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88006",
                "label": "LIDOCAINE WITH METHYLPREDNISOLONE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78316",
                "label": "Inflammatory bowel disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78455",
                "label": "Corticosteroids, inflammatory disorders",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_492",
                "label": "Methylprednisolone",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75654",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75647",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75640",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            }
        ]
    }
}